메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

'김갑성' 기자의 전체기사

Picarro Appoints Haavard Oestensen Chief Commercial and…

SANTA CLARA, Calif., Jan. 27, 2026 -- Picarro, Inc., a global leader in real-time emissions monitoring and advanced gas analysis solutions, today announced the appointment of Haavard Oestensen as Chief Commercial and Product Officer. In this role, Oestensen will lead Picarro's commercial and product strategy in Oil & Gas as the industry undergoes a critical shift — moving from historically passive, episodic emissions and volatile organic compound (VOC) management toward continuous, proactive, technology-led emissions control. This appointment coincides with the laun
- 김갑성 기자
- 2026-01-27 00:10
BIOSeedin Winter Innovation Partnering Summit：J.P.Morgan Spo…

SAN FRANCISCO, Jan. 26, 2026 -- To enable Chinese innovative pharmaceutical companies to more efficiently connect with international resources, bioSeedin, a platform facilitating cooperation in innovative drug assets, hosted the BIOSeedin Winter Innovation Partnering Summit in San Francisco on January 11, 2026. The event centered on the "China Asset Showcase", providing an exclusive international roadshow and licensing cooperation forum dedicated to Chinese innovative drugs. The summit brought together over 500 industry representatives from more than ten countries and regions
- 김갑성 기자
- 2026-01-26 22:00
Jin Medical International Ltd. To Host Management Fireside…

CHANGZHOU, China, Jan. 26, 2026 -- Jin Medical International Ltd. (NASDAQ: ZJYL) ("Jin Medical", and together with all its subsidiaries, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment in China, announced today that its Chief Executive Officer, together with the Company's management team, will host a fireside chat at 8:00 pm EST on February 1, 2026. The discussion will provide insights into the Company's recent strategic priorities and long-term growth considerations. The Company also announced the launch of its updated corporate
- 김갑성 기자
- 2026-01-26 21:57
Divamics Showcases Lead Autoimmune Program DVI-001 and…

SAN FRANCISCO, Jan. 26, 2026 -- Divamics (DIVAMICS), an AI-driven biotechnology company specializing in high-precision molecular discovery, highlighted the significant advancement of its internal pipeline during the Biotech Showcase™ at JPM Week 2026. The company provided updated milestones for its lead autoimmune program, DVI-001, and announced the first disclosure of DVI-004, a promising new metabolic disease program generated by its proprietary AI platform. The presentation centered on Divamics' ability to bridge the gap between AI-driven prediction and clinical-ready assets.
- 김갑성 기자
- 2026-01-26 20:00
Gu Sheng Tang Donates S$1.06 Million to NTU Singapore to Ad…

SINGAPORE, Jan. 26, 2026 -- Leading Traditional Chinese Medicine (TCM) healthcare group Gu Sheng Tang TCM and Nanyang Technological University, Singapore (NTU Singapore) officially launched the Gu Sheng Tang Traditional Chinese Medicine Education and Research Programme today. As part of the programme, Gu Sheng Tang TCM has donated S$1.06 million to NTU, aimed at advancing TCM talent development and evidence-based research in Singapore, while supporting the country's broader healthcare ecosystem. The launch was formalised at a signing ceremony at PARKROYAL COLLECTION Pickering,
- 김갑성 기자
- 2026-01-26 18:00
WuXi Biologics and HanchorBio Enter Strategic Partnership to…

SHANGHAI, Jan. 26, 2026 -- WuXi Biologics (2269.HK), a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and HanchorBio Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseases, jointly announced today the signing of a strategic collaboration agreement on the development and manufacturing of multiple next-generation bi-/multi-functional fusion programs from HanchorBio's pipeline. Under the agreement, WuXi Biologics will provide integrated, end-to-end biolog
- 김갑성 기자
- 2026-01-26 17:35
HKUST President Prof. Nancy IP Engages in Global Dialogues…

HONG KONG, Jan. 26, 2026 -- Prof. Nancy IP, President of The Hong Kong University of Science and Technology (HKUST), joined global leaders at the World Economic Forum (WEF) Annual Meeting 2026 in Davos-Klosters, Switzerland. As the sole university president representing Hong Kong, she participated in high-level dialogues on neuroscience, the evolving role of universities, the future of global research, and health innovation. Held under the theme "A Spirit of Dialogue", this year's Annual Meeting convened over 3,000 esteemed leaders from government, business, civil society, an
- 김갑성 기자
- 2026-01-26 15:43
HanchorBio and WuXi Biologics Enter Strategic Partnership to…

SHANGHAI, TAIPEI and SAN FRANCISCO, Jan. 26, 2026 -- HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseases, and WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), jointly announced today the signing of a strategic collaboration agreement to support the development and manufacturing of multiple next-generation bi- and multi-functional fusion programs from HanchorBio's pipeline. Under the agreement, WuXi Biologics wi
- 김갑성 기자
- 2026-01-26 15:00
Moyom Biotechnology Announces Strategic Partnership with…

SHANGHAI, Jan. 26, 2026 -- Moyom Biotechnology recently announced a strategic partnership with WPP Group, one of the world's leading global communications and creative networks. The partnership is centered on the "Poetics of Time" brand framework and will focus on the long-term evolution of Aphranel's global brand communications. Headquartered in London, WPP Group operates in more than 100 countries worldwide, integrating capabilities across creative, media, public relations, digital, consulting, and artificial intelligence. Through the partnership, WPP will draw on i
- 김갑성 기자
- 2026-01-26 13:56
Swan Defence and Heavy Industries Limited Secures Chemi…

MUMBAI, India, Jan. 26, 2026 -- Marking a major milestone, Swan Defence and Heavy Industries Limited (SDHI) announced the signing of its first newbuild contract for six (6) IMO Type II chemical tankers, each of 18,000 DWT, to be constructed at its revitalized shipyard in Gujarat, India. Valued at USD 227 million, the contract from leading European shipowner Rederiet Stenersen AS, the first and the largest chemical tanker order awarded to an Indian shipyard, reaffirming SDHI's capabilities in delivering complex, world-class commercial vessels. The agreement includes an op
- 김갑성 기자
- 2026-01-26 13:43

이전

1 2 3 4 5 6 7 8 9 10

많이 본 기사

최근기사

2026-01-31_SAT

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 01월 31일 13시 40분